Exenatide and Weight Loss for Diabetes Prevention
NCT02084654
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Pre Diabetes
Insulin Resistance
Interventions
DRUG:
Exenatide 5 and 10 mcg 2 times a day
DRUG:
placebo
Sponsor
Stanford University